A randomised trial of active symptom control (ASC) with or without chemotherapy (CT) in the treatment of patients with malignant pleural mesothelioma. First results of the Medical Research Council/British Thoracic Society MS01 trial Source: Annual Congress 2007 - Pleural malignancy Year: 2007
Determinants of survival in patients with malignant pleural mesothelioma (MPM) managed at a single institution in Liguria, Italy Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Malignant pleural mesothelioma: new treatment modalities Source: Annual Congress 2005 - Clinical year in review Year: 2005
Neoplastic pericardial involvement as a first sign of lung cancer - diagnosis and treatment. An analysis of 33 patients treated in ICU Source: Eur Respir J 2002; 20: Suppl. 38, 76s Year: 2002
Survival trend of patients with lung cancer (LC) in Cáceres (Spain) (1991-2003). Analysis based on TNM staging, histology, modality-treatment and time-period of diagnosis Source: Eur Respir J 2007; 30: Suppl. 51, 669s Year: 2007
Breath analysis allows to predict treatment response in malignant pleural mesothelioma patients. Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease Year: 2021
Trends in mesothelioma diagnosis in Australia between 1993 and 2003 Source: Annual Congress 2005 - Old timers still around: fibres and inorganic dusts Year: 2005
Clinical outcome of Pembrolizumab (PEMB) monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC) – Reports from routine clinical care. Source: International Congress 2019 – Treatment of lung cancer Year: 2019
Comparative analysis of lung malignant tumors (LMT) incidence in 1999 and 2004 Source: Eur Respir J 2006; 28: Suppl. 50, 88s Year: 2006
Bronchoscopy - any use for follow-up of operated lung cancer (LC) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 17s Year: 2001
Quality of life after lung resection due to malignant neoplasm in Brazilian patients Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005
Long time survival after resection for multiple primary lung cancers. A population-based study Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005
Invasive aspergillosis (IA) in autopsy material in patients (pts) treated in the national TB and lung diseases research institute in years 1993 - 2000 Source: Eur Respir J 2002; 20: Suppl. 38, 355s Year: 2002
Comparison of non-small cell lung cancer (NSCLC) management and survival in 1995 and 2005 at a London teaching hospital Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015
Survival of patients resected for lung cancer in the period 1986 - 1977. Sensitivity of staging, prognostic factors, impact of adjuvant chemotherapy and radiotherapy Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001
The analysis of lung cancer patients (LCP) survival during 5 year period after diagnosis of disease Source: Eur Respir J 2006; 28: Suppl. 50, 88s Year: 2006
Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer Source: Annual Congress 2005 - What's new in the pleura Year: 2005
Prognostic value of treatment outcomes patients with malignant pleural mesothelioma Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Screening for incidence of lung cancer (LC) among the patients with pulmonary pathology (with special reference to histological subtype and TNM-staging system) in Ukraine Source: Eur Respir J 2005; 26: Suppl. 49, 537s Year: 2005